Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis

Eric Lawitz, Mihály Makara, Ulus Salih Akarca, Paul J. Thuluvath, Liliana Lucia Preotescu, Peter Varunok, Rosa Ma Morillas, Coleen Hall, Niloufar Mobashery, Rebecca Redman, Tami Pilot-Matias, Regis A. Vilchez, Christophe Hézode

Producción científica: Article › revisión exhaustiva

79 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis'. En conjunto forman una huella única.

Pharmacology, Toxicology and Pharmaceutical Science